News from proove biosciences, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 02, 2017, 07:33 ET 7th Peer-Reviewed Study Published In The Last 7 Months Validates Value Of Proove Precision Medicine Technology

Proove® Biosciences, Inc. announces yet another new peer-reviewed study demonstrating that treatment decisions informed by Proove Opioid Risk®...

Jun 21, 2017, 07:32 ET Large Peer-Reviewed Prospective Outcomes Study Of Proove Opioid Risk® Shows Positive Patient Benefits And Strong Physician Ratings

Proove® Biosciences, Inc. announces a new peer-reviewed study demonstrating that treatment decisions informed by Proove Opioid Risk® result in better ...

Jun 15, 2017, 08:30 ET New Peer-Reviewed Clinical Study Demonstrates Accuracy Of Proove Opioid Risk® To Predict Opioid Abuse In A Primary Care Setting

Proove® Biosciences, Inc. announces a new peer-reviewed study demonstrating the accuracy of Proove Opioid Risk® to help primary care physicians...

Jun 08, 2017, 20:29 ET Proove Responds To Inaccurate Stories From STAT News And Yesterday's Related Federal Document Subpoena And Search Warrant

Yesterday, federal agents came to the Irvine, California office of Proove Biosciences to serve a subpoena and execute a search warrant solely related ...

May 31, 2017, 10:37 ET 90% Of Patients Achieve 40% Pain Reduction Within 60-Days In Large Precision Medicine Clinical Trial

Proove® Biosciences, Inc. announces preliminary results at the close of a large patient-centered outcomes clinical trial demonstrating 94% of...

May 10, 2017, 10:34 ET New Peer-Reviewed Clinical Study Successfully Validates The Use Of Proove Opioid Risk® To Predict Prescription Opioid Abuse

Proove® Biosciences, Inc. announces a new study validating the accuracy of precision medicine technology to predict prescription opioid abuse. This...

May 02, 2017, 12:11 ET Proove® Biosciences CEO To Speak At 5th Annual Medical Device Forum

Proove® Biosciences, Inc. announces that its founder and Chief Executive Officer, Brian Meshkin, will speak at the 5th annual 10x Medical Device...

Apr 25, 2017, 11:30 ET World's Largest DNA Biobank And Big Data Set In Chronic Pain Surpasses Milestone Of 100,000 Specimens And 28 Billion Data Points

Proove® Biosciences, Inc. announces that its Proove Nexus™ platform is the World's Largest DNA Pain Biobank and Big Data Clinical Data Set in Chronic ...

Apr 19, 2017, 11:08 ET First Published Clinical Study Successfully Uses Precision Medicine To Predict Prescription Opioid Abuse

As a Bronze Sponsor of the National Rx Drug Abuse and Heroin Summit, Proove® Biosciences, Inc. announces the first-ever peer-reviewed published...

Mar 23, 2017, 10:33 ET Proove® Biosciences CEO To Speak At 8th Annual Life Sciences CEO Forum

Proove® Biosciences, Inc. announces that its founder and Chief Executive Officer, Brian Meshkin, will join other C-level executives and experts as a...

Mar 21, 2017, 10:39 ET Proove® Biosciences Unveils New Logo Focused On The Nexus Of Healthcare

Proove® Biosciences, Inc. is proud to unveil its new logo featuring the "nexus" as its centrally-defining feature. Proove®'s name is uniquely...

Mar 16, 2017, 10:37 ET Proove® Biosciences Presents Precision Medicine Research On Pain Medications At 2017 American Academy Of Pain Medicine Annual Meeting

Proove® Biosciences, Inc. is presenting industry-leading research in precision pain medicine this week at the 2017 Annual Meeting of the American...

Mar 15, 2017, 10:34 ET A Published Peer-Reviewed Case Study Supports Use Of Proove® Biosciences Precision Medicine Technology In Post-Operative Pain

Proove Biosciences, Inc. announces publication of a case study in the peer-reviewed Journal of Medical Case Reports. This study, A Case Report...